Why Shkreli won’t talk drug prices at Congressional hearing: Turing investigated by FTC for antitrust violations
Martin Shkreli won't talk drug prices at his forthcoming Congressional hearing, because Turing Pharmaceuticals is under an FTC antitrust probe.